Corneal collagen cross-linkage,inkeratoconus

British Journal of Ophthalmology

Volumn 97, Issue 1, 2013, Pages 108-109

  Jain, Rajat ^a   Basu, Sayan ^a   Garg, Prashant ^a  

^a L V PRASAD EYE INSTITUTE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN;

CORNEAL PACHYMETRY; CROSS LINKING; DISEASE COURSE; DRUG EFFICACY; DRUG SAFETY; EYE REFRACTION; HUMAN; KERATOCONUS; KERATOMETRY; LETTER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); TREATMENT OUTCOME;

COLLAGEN; CORNEA; FEMALE; HUMANS; KERATOCONUS; MALE; PHOTOCHEMOTHERAPY; RIBOFLAVIN;

EID: 84872273269     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjophthalmol-2012-302322     Document Type: Letter

References (4)

1. O'Brart DPS, Chan E, Samaras K, et al. A randomised, prospective study to investigate the efficacy of riboflavin/ultraviolet A (370 nm) corneal collagen cross-linkage to halt the progression of keratoconus. BJO 2011;95:1519-24.
2. Goss DA, Grosvenor T. Reliability of refraction - a literature review. J Am Optom Assoc 1996;67:619-30.
3. Wittig-silva C, Witling M, Lamoureux E, et al. A Randomized Controlled Trial of Corneal Collagen Cross-linking in Progressive Keratoconus: Preliminary Results. J Refract Surg 2008;24:S720-5.
4. Lackner B, Schmidinger G, Pieh S, et al. Repeatability and reproducibility of central corneal thickness measurement with Pentacam, Orbscan, and ultrasound. Optom Vis Sci 2005;82:892-9. (Pubitemid 41566871)